InformedDNA
Provider of telehealth genetic counseling, laboratory result interpretation and reporting, pharmacogenomics decision support, molecular-diagnostics interpretation, and population-scale precision-health software for payors, employers, health systems, and life-sciences organizations. Offers telehealth counseling, laboratory report augmentation, evidence-based literature curation and meta-analysis for genomics, pharmacogenomics clinical decision support, clinical-trial recruitment and test-adjudication services, and research/educational resources.
Industries
Nr. of Employees
medium (51-250)
InformedDNA
Products
Population genomics platform
Scalable software platform for population genomic risk assessment, personalized screening pathways, integrated counseling and scheduling workflows, education modules, testing coordination, and follow-up management.
Laboratory results analysis and interpretation platform
Software and curation workflows that augment laboratory outputs with curated genomic interpretations, evidence-backed recommendations, and reporting templates for clinical and pharmacogenomic use cases.
DNAassist
Comprehensive cancer risk assessment software that automates the collection of patient and family health information for rapid cancer risk stratification and personalized screening and prevention plans.
DNAimpact
An innovative, scalable precision health platform for payors and employers that weaves genomics into medicine by screening, educating, testing, and counseling members.
Genetic Testing Utilization Management
A genetic testing utilization management solution offered by InformedDNA that uses evidence-based coverage guidelines, CPT insights, and in-house genetic experts to help health plans optimize clinical decisions, ensure accurate coding, and realize cost savings.
PGx Consulting Package
A specialized consulting program designed to help laboratories align their pharmacogenomic (PGx) testing programs with MolDx technical assessment expectations to achieve CMS reimbursement.
Population genomics platform
Scalable software platform for population genomic risk assessment, personalized screening pathways, integrated counseling and scheduling workflows, education modules, testing coordination, and follow-up management.
Laboratory results analysis and interpretation platform
Software and curation workflows that augment laboratory outputs with curated genomic interpretations, evidence-backed recommendations, and reporting templates for clinical and pharmacogenomic use cases.
DNAassist
Comprehensive cancer risk assessment software that automates the collection of patient and family health information for rapid cancer risk stratification and personalized screening and prevention plans.
DNAimpact
An innovative, scalable precision health platform for payors and employers that weaves genomics into medicine by screening, educating, testing, and counseling members.
Genetic Testing Utilization Management
A genetic testing utilization management solution offered by InformedDNA that uses evidence-based coverage guidelines, CPT insights, and in-house genetic experts to help health plans optimize clinical decisions, ensure accurate coding, and realize cost savings.
PGx Consulting Package
A specialized consulting program designed to help laboratories align their pharmacogenomic (PGx) testing programs with MolDx technical assessment expectations to achieve CMS reimbursement.
Services
Remote genetic counseling by licensed, board-certified genetic counselors for pre-test evaluation, test selection, result interpretation, and post-test management.
Analytical services and software that augment laboratory outputs with curated literature, clinical interpretation, pharmacogenomics reporting, and actionable recommendations.
Implementation of precision-health programs including genomic risk assessment, member segmentation, education, testing coordination, and care-pathway recommendations.
Services to recruit, screen, adjudicate genetic-test results, and retain genetically eligible participants using telehealth-directed genetic screening and site auditing.
Programs to manage testing utilization, develop medical policy, and implement cost-control measures for genetic testing at the payor and health-system level.
Remote genetic counseling by licensed, board-certified genetic counselors for pre-test evaluation, test selection, result interpretation, and post-test management.
Analytical services and software that augment laboratory outputs with curated literature, clinical interpretation, pharmacogenomics reporting, and actionable recommendations.
Implementation of precision-health programs including genomic risk assessment, member segmentation, education, testing coordination, and care-pathway recommendations.
Services to recruit, screen, adjudicate genetic-test results, and retain genetically eligible participants using telehealth-directed genetic screening and site auditing.
Programs to manage testing utilization, develop medical policy, and implement cost-control measures for genetic testing at the payor and health-system level.
Expertise Areas
- Telehealth genetic counseling
- Genomic result interpretation and laboratory report augmentation
- Pharmacogenomics clinical decision support and medication-safety reporting
- Population genomics program implementation and risk stratification
Key Technologies
- Telehealth platforms for genetic counseling
- Clinical decision support systems for genomics
- Laboratory results analysis and interpretation platforms
- Pharmacogenomics evidence curation and meta-analysis pipelines
News & Updates
Announcement of acquisition to expand pharmacogenomics capabilities.
Partnership with a breast-cancer education foundation to expand access to screening recommendations and genetic counseling.
Partnership announced to offer personalized obesity care and treatment planning based on genetics.
Announcement to launch a patient-centric precision health platform as part of strategic repositioning.
Company featured discussing applied genomics for population health.
Coverage describing the role of genetic counseling in improving genetic screening and clinical-trial success.
Announcement of acquisition to expand pharmacogenomics capabilities.
Partnership with a breast-cancer education foundation to expand access to screening recommendations and genetic counseling.
Partnership announced to offer personalized obesity care and treatment planning based on genetics.
Announcement to launch a patient-centric precision health platform as part of strategic repositioning.
Company featured discussing applied genomics for population health.
Coverage describing the role of genetic counseling in improving genetic screening and clinical-trial success.